Researcher Profile Statistics: Kamal, S.M.
Geo Map
Region
#
AF - Africa
7
NA - North America
4
EU - Europe
1
Unknown
28
Total
40
Country
#
EG - Egypt
5
US - United States of America
4
CI - Cote d'Ivoire
2
AT - Austria
1
Unknown
28
Total
40
City
#
Al Fayyum
4
Mountain View
4
Abidjan
1
Béoumi
1
Vienna
1
Unknown
29
Total
40
Most downloaded files
#
ID: 3190 - Evaluation of serum fibrotic markers; CTGF, IL-17and TGF-β1 versus liver.pdf - ITEM:( 123456789/249)
40
Total
40
Most bitstream per type viewed
#
ID: all -
40
ID: other -
0
ID: journal -
0
ID: conference -
0
ID: patent -
0
ID: book -
0
ID: dataset -
0
ID: selected -
0
Total
40
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Tot
2019
0 0
0 0 0 0
1 1 0 0
0 0
2
2020
0 0
0 0 0 1
0 0 0 0
0 0
1
2021
0 0
0 0 4 0
0 0 0 0
1 0
5
2022
4 0
0 0 0 0
0 0 0 0
1 2
7
2023
0 1
0 2 1 10
3 0 0 0
1 1
19
2024
1 0
0 0 0 0
0 0 0 0
0 0
1
Ever
40
Geo Map
Region | # |
---|---|
AF - Africa | 7 |
NA - North America | 4 |
EU - Europe | 1 |
Unknown | 28 |
Total | 40 |
Country | # |
---|---|
EG - Egypt | 5 |
US - United States of America | 4 |
CI - Cote d'Ivoire | 2 |
AT - Austria | 1 |
Unknown | 28 |
Total | 40 |
City | # |
---|---|
Al Fayyum | 4 |
Mountain View | 4 |
Abidjan | 1 |
Béoumi | 1 |
Vienna | 1 |
Unknown | 29 |
Total | 40 |
Most downloaded files | # |
---|---|
ID: 3190 - Evaluation of serum fibrotic markers; CTGF, IL-17and TGF-β1 versus liver.pdf - ITEM:( 123456789/249) | 40 |
Total | 40 |
Most bitstream per type viewed | # |
---|---|
ID: all - | 40 |
ID: other - | 0 |
ID: journal - | 0 |
ID: conference - | 0 |
ID: patent - | 0 |
ID: book - | 0 |
ID: dataset - | 0 |
ID: selected - | 0 |
Total | 40 |
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Tot | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2019 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 2 |
2020 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
2021 | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 5 |
2022 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 7 |
2023 | 0 | 1 | 0 | 2 | 1 | 10 | 3 | 0 | 0 | 0 | 1 | 1 | 19 |
2024 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
Ever | 40 |